← Leaderboards
R Hal Scofield
Oklahoma City Va Medical Center
$18,334,476
Attributed
$18,644,727
Total exposure
21
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,644,727 · 17
VA$0 · 4
By mechanism
U54$8,666,569 · 3
R01$3,684,885 · 3
P50$3,563,256 · 3
R21$1,173,115 · 3
K24$738,580 · 1
P20$541,681 · 1
Top collaborators
- David S Chia2 shared
- David T Wong2 shared
Others in their field
Top investigators on “S Syndrome”
- David Heimbrook · Leidos Biomedical Research, Inc.$365,165,418
- George R Seage · Abt Associates, Inc.$241,364,559
- Barbara Driver · Westat, Inc.$177,853,041
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$174,377,607
- Michelle Vargas · Ppd Development Lp$163,846,102
- Judith S. Currier · University Of California Los Angeles$149,333,820
Research focus
S SyndromeAffectSjogren&AposAutoimmune DiseasesSystemic Lupus ErythematosusCohortMedicalOklahomaCellsB-LymphocytesResearch PersonnelPathogenesisClinical ResearchGenesLupusProductionWomanImmuneAutoimmunityBaseTranslational ResearchMediatingPhenotypeSalivary Glands
Grant awards (73)
Clinical Resources Core$636,668
U54 · FY2025 · GM · contact PI
Saliva Anti-SSA/Ro and Anti-SSB/La for Early Detection of Sjögrenâs and SICCA Syndromes$205,001
R21 · FY2025 · DE
DEI Summer Research Program$0
I01 · FY2025 · VA · contact PI
Sex Chromosome Aneuploidies in Autoimmune Disease$0
I01 · FY2025 · VA · contact PI
Clinical Resources Core$636,668
U54 · FY2024 · GM · contact PI
Saliva Anti-SSA/Ro and Anti-SSB/La for Early Detection of Sjögrenâs and SICCA Syndromes$260,375
R21 · FY2024 · DE
Sex Chromosome Aneuploidies in Autoimmune Disease$0
I01 · FY2024 · VA · contact PI
Clinical Resources Core$616,800
U54 · FY2023 · GM · contact PI
Sjogren's Syndrome Pathogenic Autoantibodies$291,045
R01 · FY2023 · DE · contact PI
Sex Chromosome Aneuploidies in Autoimmune Disease$0
I01 · FY2023 · VA · contact PI
Autoimmunity in Post-Traumatic Stress Disorder$0
I01 · FY2023 · VA · contact PI
Clinical Research Core$626,720
U54 · FY2022 · GM · contact PI
Sjogren's Syndrome Pathogenic Autoantibodies$290,317
R01 · FY2022 · DE · contact PI
Autoimmunity in Post-Traumatic Stress Disorder$0
I01 · FY2022 · VA · contact PI
Clinical Research Core$617,911
U54 · FY2021 · GM · contact PI
Sjogren's Syndrome Pathogenic Autoantibodies$290,408
R01 · FY2021 · DE · contact PI
ENBA2 in the pathogenesis of Sjogren's Syndrome$157,500
R21 · FY2021 · DE · contact PI
Autoimmunity in Post-Traumatic Stress Disorder$0
I01 · FY2021 · VA · contact PI
Sex Chromosome Aneuploidies in Autoimmune Disease$0
I01 · FY2021 · VA · contact PI
Clinical Research Core$632,172
U54 · FY2020 · GM · contact PI
ENBA2 in the pathogenesis of Sjogren's Syndrome$189,000
R21 · FY2020 · DE · contact PI
Autoimmunity in Post-Traumatic Stress Disorder$0
I01 · FY2020 · VA · contact PI
Clinical Research Core$634,779
U54 · FY2019 · GM · contact PI
Sex chromosome aneuploidies in autoimmune disease$0
I01 · FY2019 · VA · contact PI
ShEEP Request for Peggy Sue by Bio-Techne$0
IS1 · FY2019 · VA · contact PI
Clinical Research Core$599,194
U54 · FY2018 · GM · contact PI
Mitochondrial dysfunction, metabolic syndrome and oxidative damage in Sjogren's Syndrome$164,266
R21 · FY2018 · DE · contact PI
Sex chromosome aneuploidies in autoimmune disease$0
I01 · FY2018 · VA · contact PI
Clinical Resources Key Componient Activity$747,234
U54 · FY2017 · GM · contact PI
Mitochondrial dysfunction, metabolic syndrome and oxidative damage in Sjogren's Syndrome$196,973
R21 · FY2017 · DE · contact PI
Sex chromosome aneuploidies in autoimmune disease$0
I01 · FY2017 · VA · contact PI
Clinical Resources Key Componient Activity$747,234
U54 · FY2016 · GM · contact PI
Sex chromosome aneuploidies in autoimmune disease$0
I01 · FY2016 · VA · contact PI
Clinical Resources Key Componient Activity$747,234
U54 · FY2015 · GM · contact PI
Pathogenic B Cells in Sjogren's Syndrome$378,973
P50 · FY2015 · AR · contact PI
Clinical Core$302,418
P50 · FY2015 · AR · contact PI
Sex chromosome aneuploidies in autoimmune disease$0
I01 · FY2015 · VA · contact PI
Clinical Resources Key Componient Activity$747,234
U54 · FY2014 · GM · contact PI
Pathogenic B Cells in Sjogren's Syndrome$379,227
P50 · FY2014 · AR · contact PI
Clinical Core$302,677
P50 · FY2014 · AR · contact PI
Sex chromosome aneuploidies in autoimmune disease$0
I01 · FY2014 · VA · contact PI
Clinical Resources Key Componient Activity$676,721
U54 · FY2013 · GM · contact PI
Pathogenic B Cells in Sjogren's Syndrome$360,496
P50 · FY2013 · AR · contact PI
Clinical Core$287,776
P50 · FY2013 · AR · contact PI
Sex chromosome aneuploidies in autoimmune disease$0
I01 · FY2013 · VA · contact PI
Pathogenic B Cells in Sjogren's Syndrome$533,142
P50 · FY2012 · AR · contact PI
Clinical Core$310,012
P50 · FY2012 · AR · contact PI
Sex chromosome aneuploidies in autoimmune disease$0
I01 · FY2012 · VA · contact PI
Pathogenic B Cells in Sjogren's Syndrome$417,776
P50 · FY2011 · AR · contact PI
Clinical Core$290,759
P50 · FY2011 · AR · contact PI
Sjogren's model with anti-Ro/La and Salivary Pathology and Dysfunction$285,906
R01 · FY2010 · DE · contact PI
The X Chromosome in Systemic Lupus Erythematosus$264,371
R01 · FY2010 · AR · contact PI
Sjogren's model with anti-Ro/La and Salivary Pathology and Dysfunction$288,159
R01 · FY2009 · DE · contact PI
The X Chromosome in Systemic Lupus Erythematosus$267,041
R01 · FY2009 · AR · contact PI
INSULIN RESISTANCE AND GLUCOCORTICOIDS$204,766
P20 · FY2009 · MD · contact PI
Sjogren's model with anti-Ro/La and Salivary Pathology and Dysfunction$287,546
R01 · FY2008 · DE · contact PI
The X Chromosome in Systemic Lupus Erythematosus$267,041
R01 · FY2008 · AR · contact PI
INSULIN RESISTANCE AND GLUCOCORTICOIDS$201,082
P20 · FY2008 · MD · contact PI
Sjogren's model with anti-Ro/La and Salivary Pathology and Dysfunction$290,149
R01 · FY2007 · DE · contact PI
The X Chromosome in Systemic Lupus Erythematosus$272,999
R01 · FY2007 · AR · contact PI
Genetics of Severe Systemic Lupus Erythematosus (SLE) defined by thrombocytopenia$154,956
K24 · FY2007 · AR · contact PI
INSULIN RESISTANCE AND GLUCOCORTICOIDS$135,833
P20 · FY2007 · MD · contact PI
Sjogren's model with anti-Ro/La and Salivary Pathology and Dysfunction$304,076
R01 · FY2006 · DE · contact PI
The X chromosome in systemic lupus erythematosus$285,827
R01 · FY2006 · AR · contact PI
Genetics of Severe SLE defines by thrombocytopenia$151,229
K24 · FY2006 · AR · contact PI
Genetics of Severe SLE defines by thrombocytopenia$147,610
K24 · FY2005 · AR
GLUCOSAMINE AND INSULIN RESISTANCE$7,559
M01 · FY2005 · RR
Genetics of Severe SLE defines by thrombocytopenia$144,098
K24 · FY2004 · AR
Glucosamine and Insulin Resistance$56,671
M01 · FY2004 · RR
Genetics of Severe SLE defined by thrombocytopenia$140,687
K24 · FY2003 · AR
THROMBOCYTOPENIA AND THE GENETICS OF SEVERE LUPUS$0
P50 · FY2002 · AR
A MODEL OF SJOGREN'S SYNDROME WITH ANTI-RO/LA ANTIBODIES$100,000
R55 · FY2001 · AR
B27 BINDING BACTERIAL AND SELF PEPTIDES IN B27 ARTHRITIS$112,411
R29 · FY2000 · AR